Every 8-K that SiriusPoint Ltd. (SPNT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow SPNT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SPNT filings page.
SiriusPoint Ltd. reported strong results for the quarter and six months ended June 30, 2026. For the second quarter, net income available to common shareholders was $68.6 million, or $0.58 per diluted share, and operating earnings per share were $0.67. Annualized return on equity was 12.0%, with operating ROE of 13.8%. The consolidated combined ratio was 88.5%, and the Core combined ratio was 91.4%.
For the first half of 2026, net income available to common shareholders rose to $168.2 million, up 44% versus the prior year, with diluted EPS of $1.40 and operating EPS of $1.37, up 17%. The Core combined ratio improved to 90.1%, reflecting materially lower catastrophe losses of $6.7 million compared with $67.4 million a year earlier. Book value per diluted common share excluding AOCI increased 8% since December 31, 2025 to $19.48, supported by underwriting profitability and a BSCR capital ratio of 239%. Year to date, SiriusPoint repurchased $95 million of common shares, contributing to $295 million of total capital returned in 2026.
SiriusPoint Ltd. reported results of its 2026 annual general meeting of shareholders held on May 20, 2026. Shareholders elected two Class I directors, Susan L. Cross and Sabra R. Purtill, each to serve until the 2029 annual meeting, with strong support in the “for” votes.
Shareholders also approved, on an advisory and non-binding basis, the compensation of the company’s named executive officers as disclosed in the proxy statement. They further approved the appointment of PricewaterhouseCoopers LLP as independent auditor through the 2027 annual meeting and authorized the board’s Audit Committee to set the auditor’s remuneration.
In addition, shareholders approved the SiriusPoint SharePlan, which had been adopted by the board on February 12, 2026, subject to shareholder approval. The company noted that certain voting limitations in its Bye-laws were not applied in tabulating votes for this meeting.
SiriusPoint Ltd. reported strong first-quarter 2026 results, with net income available to common shareholders of $99.6 million, or $0.82 diluted EPS, and total revenue of $774.6 million. Operating earnings per share were $0.70, up 37% from $0.51 a year earlier.
The consolidated combined ratio improved to 87.8% from 91.4%, while the Core combined ratio improved to 88.9% from 95.4%, reflecting lower catastrophe losses and better underlying underwriting performance. Net earned premium rose to $638.9 million, and Core underwriting income more than doubled to $70.9 million.
Insurance & Services gross written premium grew 7.8% to $684.6 million, while Reinsurance gross written premium decreased 10.0% to $319.2 million as the company remained disciplined in softer markets. Book value per diluted common share excluding AOCI increased about 5% since year-end to $18.98.
SiriusPoint returned $242 million of capital to shareholders in the quarter, including $42 million of share repurchases, and raised its 2026 buyback commitment to the full $174 million authorization. The balance sheet remained strong, with a BSCR capital ratio of 242% and recent financial strength rating upgrades to ‘A’ from three agencies.
SiriusPoint Ltd. has appointed Sabra R. Purtill to its Board of Directors effective March 25, 2026, as a Class I director serving until the annual general meeting scheduled for May 20, 2026. She brings 40 years of insurance and financial services experience and has held senior roles at AIG, Hartford Financial Services Group, Assured Guaranty and ACE Limited (now Chubb.
The Board determined that Ms. Purtill is an independent director and an “audit committee financial expert”. She will serve on the Audit Committee and the Risk & Capital Management Committee and receive the same compensation as other non‑employee directors. Directors Franklin (Tad) Montross IV and Peter W. H. Tan will not stand for reelection, with their Board and committee service ending after the May 20, 2026 annual meeting; their decision is stated as not due to any disagreement with the company.
SiriusPoint Ltd. outlined the exit terms for Rob Gibbs, President & Chief Executive Officer of SiriusPoint International Insurance Corporation (publ), following his previously announced departure. SiriusPoint International and Mr. Gibbs signed a Settlement Agreement on March 17, 2026.
Under the agreement, Mr. Gibbs will receive a severance payment of 401,700 GBP, inclusive of payment in lieu of his six‑month notice period, any pro‑rated 2026 bonus entitlement, and contractual severance, paid in 12 equal monthly installments after his last employment day on April 30, 2026. He will not receive a bonus for 2025.
SiriusPoint International will seek to continue his private medical insurance coverage through April 30, 2027 and life assurance coverage through December 31, 2026, and will pay 3,000 GBP in lieu of life assurance for the period from January 1 through April 30, 2027, all subject to applicable taxes and National Insurance. The agreement includes ongoing confidentiality, non‑disparagement, non‑compete and non‑solicitation obligations and a general release of claims by Mr. Gibbs.
SiriusPoint Ltd. is reorganizing its operations into four business areas: Global P&C Programs, Global Reinsurance, Global Accident & Health, and a London Market Specialty division that includes Lloyd’s. The company is combining its North America and International Programs into a single Global P&C Programs division led by Patrick Charles.
The new London Market Specialty division, highlighting the importance of SiriusPoint’s London platform and Syndicate 1945, will be led by David Govrin, who also serves as CEO Global Reinsurance. As part of these changes, Rob Gibbs, President & CEO of SiriusPoint International, will leave the company under a mutual separation agreement based on the Executive Severance Plan. The company furnished a press release as Exhibit 99.1 describing these structural changes and the leadership transition.
SiriusPoint Ltd. reported very strong fourth-quarter and full-year 2025 results, highlighting profitable growth and capital returns. Net income available to common shareholders reached $240 million in Q4, or $1.97 per diluted share, with operating earnings per share of $0.70. Annual net income was $444 million, or $3.64 per diluted share, and operating earnings per share rose 49% to $2.55. The company delivered an annualized return on equity of 44.9% in Q4 and 22.1% for the year, with operating ROE of 16.2%. Gross written premiums grew 16% in 2025 and the Core combined ratio was 91.7%, indicating solid underwriting profitability.
Book value per common share increased to $19.40, while book value per diluted share excluding AOCI rose 23.6% to $18.10. SiriusPoint announced it will redeem all Series B preference shares, expecting its leverage ratio to fall to about 23%, and plans to repurchase $100 million of common shares over the next 12 months. The balance sheet remained strong with a year-end BSCR estimate of 247%. Strategic actions included selling a 49% stake in Arcadian for $140.4 million (with an expected pre-tax gain of about $25 million in the first quarter of 2026) and agreements to acquire Assist America for approximately $42.5 million and the World Nomads travel insurance business to expand medical and travel assistance capabilities.
SiriusPoint Ltd. announced that its wholly owned subsidiary International Medical Group (IMG) has signed a definitive agreement to acquire the World Nomads travel insurance business from nib Group. World Nomads generates approximately $40 million of gross written premium and is a global travel insurance and lifestyle brand.
The deal is expected to significantly expand IMG’s travel insurance distribution, adding a broad base of independent, lifestyle, and adventure travelers and extending its reach to Australia, Brazil, and Canada. Together with IMG’s recent acquisition of Assist America, which produces around $20 million in annual assistance revenues, the combination creates an integrated travel insurance and assistance platform.
The company states that both the World Nomads and Assist America acquisitions are accretive to return on equity and earnings per share. An initial closing for the majority of World Nomads is targeted for the second or third quarter of 2026, with final closing in the second half of 2027, in each case subject to regulatory approvals and other customary conditions.
SiriusPoint Ltd. reports that a subsidiary has completed the previously announced sale of its entire equity stake in Arcadian Holdings Limited to Comet Bidco Limited, an acquisition vehicle of funds affiliated with Lee Equity Partners. Under the Share Purchase Agreement dated October 3, 2025, SiriusPoint Bermuda Insurance Company Ltd., as seller, received cash consideration of $140 million, subject to customary post-closing adjustments. The transaction closed after all customary closing conditions were met, including required regulatory approvals.
SiriusPoint Ltd. has announced the full redemption of all 8,000,000 of its 8.00% Resettable Fixed Rate Preferred Shares, Series B. The redemption will occur on February 26, 2026, retiring this entire preferred share series.
The company also stated its intent to delist and deregister the Series B Preference Shares from the New York Stock Exchange and under U.S. securities laws. These steps consolidate its capital structure by removing this listed preferred security from public trading.
SiriusPoint Ltd. completed the previously announced sale of all membership interests in ArmadaCorp Capital, LLC, the holding company of its supplemental health insurance program manager ArmadaCare, to a subsidiary of Ambac Financial Group Inc.
The Seller received $250 million in cash consideration, subject to deductions including transaction expenses. The transaction closed after satisfaction of customary closing conditions.
SiriusPoint Ltd. (SPNT) filed an 8-K stating it furnished its third-quarter 2025 results press release (Exhibit 99.1), a financial supplement (Exhibit 99.2), and an investor slide presentation (Exhibit 99.3). These materials were provided under Items 2.02 and 7.01 and are not deemed filed under the Exchange Act.
Under Item 8.01, the Audit Committee approved a quarterly cash dividend of $0.50 per share on the company’s 8.00% Resettable Fixed Rate Preference Shares, Series B, payable on November 28, 2025 to shareholders of record on November 13, 2025 (press release in Exhibit 99.4).
SiriusPoint (SPNT) announced a leadership change in finance. The company disclosed that Chief Accounting Officer and principal accounting officer Evan Cabat will resign effective October 31, 2025 to pursue another opportunity. The company stated his departure is not due to any disagreement with the Board or management on financial statements, internal controls, operations, policies, or practices.
Until the effective date, Mr. Cabat will continue in his role and support the transition. Upon his departure, Chief Financial Officer Jim McKinney will also serve as the company’s principal accounting officer, in addition to his role as principal financial officer.
SiriusPoint Ltd disclosed an amendment to its program management agreement with Arcadian and an extension of the underwriting term to December 31, 2031. The filing indicates the board did not vote to disapprove the action, allowing the company to execute the amendment. The notice references a related press release dated October 6, 2025 and is signed by Chief Legal Officer Linda S. Lin. The disclosure is brief and focuses on the contractual extension and administrative approval status rather than financial results.
SiriusPoint Ltd. announced that one of its subsidiaries entered into a definitive agreement to sell ArmadaCorp Capital, LLC, the holding company for its wholly owned supplemental health insurance program manager ArmadaCare, to a subsidiary of Ambac Financial Group Inc. for $250 million. The transaction’s closing is subject to customary closing conditions, including required regulatory approvals. The company also issued a press release describing the agreement, which is filed as an exhibit to this report.
SiriusPoint Ltd. reported that its board of directors appointed Martin Hudson as a Class III director, effective September 1, 2025. He will serve until the company’s 2028 annual general meeting of shareholders and until a successor is elected and qualified or an earlier departure.
Hudson, age 66, brings more than 40 years of international (re)insurance leadership experience, including roles as an independent non-executive director and chair across multiple insurance and reinsurance entities such as SiriusPoint International, Liberty Mutual entities, and Sirius International Managing Agency Ltd. The board concluded he should serve as a director based on his extensive industry and governance background.
The board determined that Hudson qualifies as an independent director under New York Stock Exchange and SEC rules. He will receive the same compensation as other non-employee directors and has entered into the company’s standard form of director indemnification agreement. The company stated there are no special arrangements, family relationships, or related-party transactions connected to his appointment. A press release announcing his appointment was issued on September 3, 2025 and filed as Exhibit 99.1.
On 30 Jul 2025 SiriusPoint Ltd. (NYSE: SPNT) filed an 8-K announcing adoption of an Executive Severance Plan, effective 1 Aug 2025. The plan, approved by the board the same day, governs cash, benefit and equity payouts for two groups: (i) named executives/officers and (ii) other selected employees.
Executives terminated without cause or resigning for Good Reason receive, upon signing a release:
- One-time cash equal to 52 weeks base salary
- Prior-year STI target (if exit ≤ 31 Mar) or pro-rated current-year STI (≥ 1 Apr)
- Immediate vesting of any cash bonus
- Lump-sum of employer-paid medical, dental & vision premiums for 52 weeks
Change-in-Control (CiC): If separation occurs within 12 months of a CiC, cash base-pay and STI amounts are elevated to 150 % of the standard benefit. CiC is defined as: (1) >50 % voting power transfer, (2) sale of substantially all assets, or (3) replacement of a board majority within 24 months.
Other eligible employees receive 2 weeks base pay per year of service (min 6 mths, max 52 wks) plus parallel STI, bonus and benefit terms.
Equity: pro-rated vesting of RSUs/PSUs, extended option exercise (≤3 yrs) and full vesting of buy-out awards.
The plan standardises exit economics and could aid retention during strategic reviews, but it also increases potential cash outflows in layoffs or M&A events.